Hydromorphone Immediate-Release Oral Presentations Shortage
Last Updated: May 12, 2024
Status: Current
Products Affected - Description
-
- Dilaudid oral immediate release tablet, Rhodes, 2 mg, bottle, 100 count, NDC 42858-0122-01
- Dilaudid oral immediate release tablet, Rhodes, 4 mg, bottle, 100 count, NDC 42858-0234-01
- Dilaudid oral immediate release tablet, Rhodes, 4 mg, bottle, 500 count, NDC 42858-0234-50
- Dilaudid oral immediate release tablet, Rhodes, 8 mg, bottle, 100 count, NDC 42858-0338-01
- Dilaudid oral solution, Rhodes, 1 mg/mL, 473 mL bottle, NDC 42858-0416-16
- Hydromorphone Hydrochloride oral immediate release tablet, Mallinckrodt, 2 mg, bottle, 100 count, NDC 00406-3243-01
- Hydromorphone Hydrochloride oral immediate release tablet, Mallinckrodt, 4 mg, bottle, 100 count, NDC 00406-3244-01
- Hydromorphone Hydrochloride oral immediate release tablet, Mallinckrodt, 8 mg, bottle, 100 count, NDC 00406-3249-01
- Hydromorphone Hydrochloride oral immediate release tablet, Rhodes, 2 mg, bottle, 100 count, NDC 42858-0301-01
- Hydromorphone Hydrochloride oral immediate release tablet, Rhodes, 2 mg, unit-dose blister pack, 100 count, NDC 42858-0301-25
- Hydromorphone Hydrochloride oral immediate release tablet, Rhodes, 4 mg, bottle, 100 count, NDC 42858-0302-01
- Hydromorphone Hydrochloride oral immediate release tablet, Rhodes, 4 mg, unit-dose blister pack, 100 count, NDC 42858-0302-25
- Hydromorphone Hydrochloride oral immediate release tablet, Rhodes, 8 mg, bottle, 100 count, NDC 42858-0303-01
- Hydromorphone Hydrochloride oral solution, Rhodes, 1 mg/mL, 473 mL bottle, NDC 42858-0304-16
- Hydromorphone Hydrochloride oral tablet, Rhodes, bottle, 500 count, NDC 42858-0302-50
Reason for the Shortage
-
- Rhodes has hydromorphone tablets on back order due to DEA quota/active ingredient exhaustion.
- Rhodes did not provide a reason for the shortage of Dilaudid oral presentations.
- Mallinckrodt is actively manufacturing hydromorphone tablets. Wholesalers may be allocating product.
Available Products
-
- There is insufficient supply for usual ordering.
Estimated Resupply Dates
-
- Mallinckrodt is actively manufacturing hydromorphone tablets. Wholesalers are allocating all presentations.
- Rhodes has hydromorphone 2 mg tablets and 4 mg tablets in unit-dose packaging and hydromorphone 1 mg/mL oral solution on back order and the company cannot estimate a resupply date. Hydromorphone 2 mg tablets, 4 mg tablets in 100 count and 500 count bottles, and 8 mg tablets in 100 count bottles on back order and the company estimates a release date in mid-to-late-May 2024.
- Rhodes has all Dilaudid 2 mg , 4 mg, and 8 mg tablets on back order and the company cannot estimate a release date. The Dilaudid 1 mg/mL oral solution is available in limited quantities.
Updated
Updated May 12, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created December 15, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.